2008
DOI: 10.1227/01.neu.0000317306.39203.24
|View full text |Cite
|
Sign up to set email alerts
|

Localization of Cerebrospinal Fluid Leaks by Gadolinium-Enhanced Magnetic Resonance Cisternography

Abstract: Gd-enhanced MR cisternography is a sensitive and safe imaging method for detection of CSF leaks in patients with rhinorrhea.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
70
1

Year Published

2009
2009
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(76 citation statements)
references
References 26 publications
5
70
1
Order By: Relevance
“…21 In these studies, no significant change was observed on physical and neurologic examinations, electroencephalography, and CSF findings of patients following CE-MRC with Ͻ1 mL of intrathecal Gd injection. 2,6,9,10,[12][13][14][15][16][17][22][23][24][25][26] Gd-DTPA has been reported as the safest and most recommended intrathecal contrast agent in human studies. 2,4,6,9,10 In our cohort of approximately 100 patients who had CE-MRC for at past 7 years in 2 different centers, we have not encountered a major complication.…”
Section: -20mentioning
confidence: 99%
See 1 more Smart Citation
“…21 In these studies, no significant change was observed on physical and neurologic examinations, electroencephalography, and CSF findings of patients following CE-MRC with Ͻ1 mL of intrathecal Gd injection. 2,6,9,10,[12][13][14][15][16][17][22][23][24][25][26] Gd-DTPA has been reported as the safest and most recommended intrathecal contrast agent in human studies. 2,4,6,9,10 In our cohort of approximately 100 patients who had CE-MRC for at past 7 years in 2 different centers, we have not encountered a major complication.…”
Section: -20mentioning
confidence: 99%
“…Intrathecal Gd injection is not approved by the FDA, though its safety has been reported in several pilot studies in Europe. [2][3][4]6,[9][10][11][12][13][14] Tolerance and dose limits of intrathecal Gd injection were established in animal model studies, and different Gd compounds (eg, gadodiamide, gadobenate dimeglumine, and Gd-DTPA) were compared in different experimental animal protocols. 5,[14][15][16][17] High-dose intraventricular Gd injection was reported to result in behavioral and neurologic disturbances (focal seizures, ataxia, latent tremor) with histopathologic changes (loss of oligodendroglia, astrocytic hypertrophy, and eosinophilia); on the other hand, it was concluded that these changes and distur-bance did not occur if the total injected dose wasϽ15 mL (3.3 mmol/g).…”
mentioning
confidence: 99%
“…96,97 In human studies, no gross behavioral changes, neurological alterations, or seizure activity at any time after the procedure has been reported. 5,6,109,120 Symptoms, such as postural post-lumbar puncture headache, nausea, and episodes of vomiting, were documented, but all resolved within the first 24 hours of the lumbar puncture with conservative bed rest. 109 In a prospective pilot trial in 20 patients, Aydin and colleagues 5 used a total volume of 0.5-1.0 ml of intrathecal contrast medium without any significant gross neurological, CSF, electroencephalography, or MRI changes related to the medium on the initial follow-up examination.…”
Section: Diagnosis Of Csf Rhinorrheamentioning
confidence: 99%
“…Intrathecal gadolinium application has not been recognized worldwide. In the literature, it is reported that intrathecal administration of 1 ml (0.5 mmol) Gd-DTPA does not cause neurological or behavioral abnormalities or early or late complications (14,15,26). It is also used for evaluation of CSF dynamics, CSF leaks and communication of ACs; the safety of this dose has been verified in other studies (14,15,(26)(27)(28).…”
Section: Discussionmentioning
confidence: 89%